AER002

Home
Ligands
AER002

GtoPdb Ligand ID: 13723

Synonyms: AER-002 | P2G3

Comment: AER002 is a long-acting fully human anti-SARS-CoV-2 spike protein monoclonal antibody that blocks spike-ACE2 interactions, viral attachment and infection of host cells. It was isolated from post-COVID-19 patient plasma [1].

Summary
Biological activity
Clinical data
References

No information available.

No information available.

Summary of Clinical Use
AER002 is a clinical candadate for the treament of long COVID [2].

Summary of Clinical Use

AER002 is a clinical candadate for the treament of long COVID [2].

Clinical Trials
Clinical Trial ID	Title	Type	Source	Comment	References
NCT05877508	Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)	Phase 2 Interventional	University of California, San Francisco	The outSMART-LC study is designed to evaluate efficacy as treatment for established long COVID.